hims glp-1 news Hims' copycat gamble backfires Hims & Hers Just Lost

Hims & Hers Super Bowl ad for new weight loss drugs faces backlash from health experts The lack of transparency around their labeling and description of whats in their products is of concern, says Elizabeth Glowacki, an assistant teaching professor at Northeastern University

Recruitment and retention in clinical trials in chronic kidney disease: report from national workshops with patients, caregivers and health professionals

Insert the needle at a 90-degree angle into the skin

This narrative mini-review aims to describe the involvement of the GH/IGF-1/IGF-1R axis in either mediating or responding to the effects of each of the two drug classes